ATLASBristol-Myers Squibb (BMY) earnings date: expected January 25–31
Bristol-Myers Squibb (BMY) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around January 25–31. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on BMY
| Last price | $62.48 (+1.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.7% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
| Dividend | $2.52 a year (4.03% yield) |
These figures come from the same calibrated model and valuation as the Bristol-Myers Squibb stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 25–31 (estimate). One email the day before, with ATLAS’s read on Bristol-Myers Squibb. You can switch it off at any time.
Alert me before BMY reportsFree to start. Creating an account takes under a minute.
BMY earnings at a glance
| Next report | Not announced · expected around January 25–31 (ATLAS estimate) |
|---|---|
| Last report | Oct 29, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +32.9% |
| Average move around a report | ±1.6% (last 4) |
| Sector | Healthcare · Drug Manufacturers - General |
The expected window is an ATLAS estimate: it takes the typical gap between Bristol-Myers Squibb’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Bristol-Myers Squibb earnings history: last 5 reports
Bristol-Myers Squibb last reported on Oct 29, 2026: EPS of $1.35 against an estimate of $1.21 (+11.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $1.21 | $1.35 | +11.6% | Beat | – |
| Jul 30, 2026 | $1.60 | $2.04 | +27.5% | Beat | +3.5% |
| Apr 30, 2026 | $1.42 | $1.58 | +11.3% | Beat | +1.1% |
| Mar 27, 2026 | -$3.78 | -$0.97 | +74.3% | Beat | +0.5% |
| Mar 13, 2026 | $0.05 | $0.07 | +40.0% | Beat | +1.3% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for BMY
See the fair value, the probability range and the earnings history of Bristol-Myers Squibb on its ATLAS page.
Bristol-Myers Squibb (BMY) stock analysisPlans from €3.99 a month.
Bristol-Myers Squibb earnings: frequently asked questions
When is Bristol-Myers Squibb (BMY) next earnings date?
Bristol-Myers Squibb has not announced its next report. Its last 3 reports came Oct 29, 2026, Jul 30, 2026, Apr 30, 2026, so ATLAS estimates the next one around January 25–31. This is an estimate based on that pattern, not a confirmed date.
How often does BMY beat earnings estimates?
Of its last 5 reports with a recorded result, Bristol-Myers Squibb beat the EPS estimate 5 times; the average surprise was +32.9%. Past results do not predict the next one.
How much does BMY move around earnings?
Over its last 4 reports the stock moved an average of 1.6% (absolute, from the close before the report day to the close after it), and finished higher 4 of 4 times.
Did Bristol-Myers Squibb beat earnings estimates last quarter?
Bristol-Myers Squibb last reported on Oct 29, 2026: EPS of $1.35 against an estimate of $1.21 (+11.6% surprise), a beat.
How much does BMY usually move in a day?
On a normal trading day the ATLAS model puts BMY’s one-day range at about ±1.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer